Home Pharmaxis shares soar on German deal
 

Keywords :   


Pharmaxis shares soar on German deal

2015-05-18 10:30:20| Biotech - Topix.net

Biotech Pharmaxis has sold an anti-inflammatory drug it was developing to Germany's Boehringer Ingelheim in a deal worth up to $750 million. The news pushed Pharmaxis shares to a two year high, gaining 8.5 cents, or 51.5 per cent, to 25 cents.

Tags: deal german shares soar

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.10Eastern North Pacific Tropical Weather Outlook
05.10Atlantic Tropical Weather Outlook
05.10Weekly Recap: BASF, Beckers, Allnex, Sherwin-Williams Top This Weeks Stories
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 24
05.10Hurricane Kirk Wind Speed Probabilities Number 24
05.10Hurricane Kirk Forecast Advisory Number 24
05.10Hurricane Kirk Public Advisory Number 24
More »